Comparison Overview
Medicines for All Institute
Medicines for All Institute
737 N 5th Street, Richmond, VA, 23219, US
Last Update: 03/03/2026
The Medicines for All Institute, operating under the auspices of the Virginia Commonwealth University School of Engineering, has developed an innovative model that reduces the cost of manufacturing treatments, such as HIV/AIDS therapies, by accelerating the creation of ...
Ipca Laboratories Limited
125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067
Last Update: 02/04/2026
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...
Compliance Ranges Comparison
Medicines for All Institute
Ipca Laboratories Limited
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Medicines for All Institute in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Ipca Laboratories Limited in 2026.
Incident History - Medicines for All Institute (X = Date, Y = Severity)
Medicines for All Institute cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)
Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Medicines for All Institute
Ipca Laboratories Limited
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.